Compare Aventis Pharma with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ELDER PHARMA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ELDER PHARMA SANOFI INDIA/
ELDER PHARMA
 
P/E (TTM) x 39.1 -0.2 - View Chart
P/BV x 6.9 0.1 6,792.9% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 SANOFI INDIA   ELDER PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ELDER PHARMA
Jun-14
SANOFI INDIA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs6,840380 1,800.0%   
Low Rs4,630188 2,462.8%   
Sales per share (Unadj.) Rs1,203.1491.2 244.9%  
Earnings per share (Unadj.) Rs165.3-3.2 -5,194.3%  
Cash flow per share (Unadj.) Rs209.914.4 1,456.5%  
Dividends per share (Unadj.) Rs84.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs963.6376.5 255.9%  
Shares outstanding (eoy) m23.0320.54 112.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.80.6 824.4%   
Avg P/E ratio x34.7-89.3 -38.9%  
P/CF ratio (eoy) x27.319.7 138.6%  
Price / Book Value ratio x6.00.8 789.0%  
Dividend payout %50.80-   
Avg Mkt Cap Rs m132,0785,833 2,264.2%   
No. of employees `0003.3NA-   
Total wages/salary Rs m4,0682,179 186.7%   
Avg. sales/employee Rs Th8,393.8NM-  
Avg. wages/employee Rs Th1,232.4NM-  
Avg. net profit/employee Rs Th1,153.0NM-  
INCOME DATA
Net Sales Rs m27,70810,089 274.6%  
Other income Rs m897257 349.6%   
Total revenues Rs m28,60510,346 276.5%   
Gross profit Rs m6,235-792 -787.3%  
Depreciation Rs m1,027361 284.3%   
Interest Rs m72,756 0.3%   
Profit before tax Rs m6,098-3,653 -166.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m2,292125 1,831.4%   
Profit after tax Rs m3,806-65 -5,824.0%  
Gross profit margin %22.5-7.8 -286.7%  
Effective tax rate %37.6-3.4 -1,097.1%   
Net profit margin %13.7-0.6 -2,120.7%  
BALANCE SHEET DATA
Current assets Rs m15,9229,240 172.3%   
Current liabilities Rs m6,2359,998 62.4%   
Net working cap to sales %35.0-7.5 -465.5%  
Current ratio x2.60.9 276.3%  
Inventory Days Days6446 137.4%  
Debtors Days Days2160 34.8%  
Net fixed assets Rs m7,53910,124 74.5%   
Share capital Rs m230206 111.8%   
"Free" reserves Rs m21,9625,582 393.4%   
Net worth Rs m22,1927,734 287.0%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m29,83922,882 130.4%  
Interest coverage x872.1-0.3 -268,111.5%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.90.4 210.6%   
Return on assets %12.811.8 108.7%  
Return on equity %17.2-0.8 -2,029.6%  
Return on capital %27.522.3 123.3%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m7,587307 2,474.6%   
Fx outflow Rs m7,145125 5,702.3%   
Net fx Rs m442181 243.8%   
CASH FLOW
From Operations Rs m3,73911,754 31.8%  
From Investments Rs m-731-561 130.4%  
From Financial Activity Rs m-1,972-6,762 29.2%  
Net Cashflow Rs m1,0364,432 23.4%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 7.5 192.0%  
FIIs % 14.6 16.8 86.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 36.1 29.1%  
Shareholders   15,184 16,479 92.1%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALEMBIC PHARMA  CADILA HEALTHCARE  

Compare SANOFI INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Nov 11, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - WYETH LTD COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS